ACSL4 and nasopharyngeal carcinoma: The results of CCK8 assay showed that K383 deacetylation of ACSL4 could inhibit ferroptosis in NPC cells, while ACSL4 acetylation could promote ferroptosis, which could be inhibited after treated with Fer-1 (Fig. 9A).